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Abstract
Background:  Gene-gene and gene-environment interactions involved in the metabolism of
carcinogens may increase the risk of cancer. Our objective was to measure the interactions
between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1,
SULT1A1 and cigarette smoking in colorectal cancer (CRC).
Methods: A case-only design was conducted in a Chinese population including 207 patients with
sporadic CRC. Unconditional logistic regression analysis was performed adjusting for age, gender,
alcohol consumption, and cigarette smoking.
Results: The interaction odds ratio (COR) for the gene-gene interaction between CYP1B1 1294G
and SULT1A1 638A allele was 2.68 (95% CI: 1.16–6.26). The results of the gene-environment
analyses revealed that an interaction existed between cigarette smoking and the CYP1B1 1294G
allele for CRC (COR = 2.62, 95%CI: 1.01–6.72), the COR for the interaction of CYP1B1 1294G
and smoking history > 35 pack-years was 3.47 (95%CI: 1.12–10.80). No other significant gene-gene
and gene-environment interactions were observed.
Conclusion: Our results showed that the interaction between polymorphisms in CYP1B1 1294G
and SULT1A1*2 may play a significant role on CRC in the Chinese population. Also, it is suggested
that the association between cigarette smoking and CRC could be differentiated by the CYP1B1
1294G allele.
Background
Colorectal cancer (CRC) is the third most common malig-
nant tumor, (after lung and breast cancer) worldwide [1].
It has been estimated that there were about 1 million new
cases in 2002. China is a nation with relatively low inci-
dence of CRC, being the fifth or sixth most common cause
of cancer death in the country. Recently however, the inci-
dence rate of CRC has been increasing rapidly in China
[2]. The etiology of CRC is likely to be multifaceted. About
5%–10% of CRC can be attributed to inherited high-pen-
etrance genes; the other 90% may be attributed to diet,
lifestyle factors and low-penetrance genes [3,4]. Tobacco
smoking is a potential risk factor for CRC [3,5-7]. The
burning of tobacco produces a wide variety of carcino-
Published: 30 June 2007
BMC Cancer 2007, 7:115 doi:10.1186/1471-2407-7-115
Received: 5 February 2007
Accepted: 30 June 2007
This article is available from: http://www.biomedcentral.com/1471-2407/7/115
© 2007 Fan et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cancer 2007, 7:115 http://www.biomedcentral.com/1471-2407/7/115
Page 2 of 8
(page number not for citation purposes)
gens, including aromatic amines (AAs), heterocyclic
amines (HAAs), polycyclic aromatic hydrocarbons
(PAHs) and N-nitroso compounds which are metabolized
by some Phase I and Phase II metabolic enzymes, such as
cytochrome P450s, glutathione S-transferases (GSTs) and
sulfotransferases (SULTs) etc. Many of these enzymatic
genes are polymorphic and can affect metabolic capabili-
ties, which may result in a differential susceptibility to
CRC.
A number of cytochrome P450s, including CYP1A2 and
CYP1B1, are involved in the activation of AAs and HAAs
[8,9], while CYP2E1 is an ethanol inducible enzyme
involved in the activation of N-nitrosamines. A single
base C to A change in intron 1 at position 734 down-
stream was the first identified polymorphism of the
CYP1A2 gene, and the AA genotype may be associated
with increased activity of the enzyme [10]. The Leu432Val
amino acid substitution is due to a single C to G base pair
change at position 1294 in the CYP1B1 gene. This poly-
morphic variant may cause some altered catalytic specifi-
city with various substrates. In particular, Leu432 variant
combined with Arg48, Ser119 and Asn 453 is slightly
more active (1.2- to 1.5-fold) than other CYP1B1 enzymes
in carcinogen metabolism, such as benzo (a) pyrene [11].
Furthermore, previous studies suggested that the C-to-G
transition resulted in an increase of p53 [12]. RsaI poly-
morphism located in the 5'-flanking region of the CYP2E1
was found to affect the transcriptional regulation of the
gene, leading to a higher expression level of mRNA among
individuals [13].
GSTs belong to a superfamily of detoxification enzymes
that facilitate the inactivation of chemical carcinogens and
environmental toxic compounds, such as HAAs and
PAHs.  GSTM1  and  GSTT1  genes are polymorphic and
encode the GST-μ and GST-θ enzymes respectively. For
both GSTM1 and GSTT1, the "null" alleles result in a com-
plete loss of enzyme function. SULTs, phase II enzymes
with dual functions, are associated with the detoxification
and activation of different carcinogens, as well as the reg-
ulation of many hormones [14]. SULT1A1 is involved in
the bioactivation of HAAs and PAHs [15]. One polymor-
phism of SULT1A1 located in the coding region (638G to
A) leads to an Arg213His amino acid change, and the var-
iant A allele (SULT1A1*2) is associated with remarkably
reduced sulforansferase activity in platelets compared
with the wild-type G allele (SULT1A1*1) [16].
Cigarette smoking and the aforementioned genetic poly-
morphisms derived from distinct pathways may be associ-
ated with CRC. However, minimal information has been
previously reported about possible gene-gene and gene-
environment interactions. The present study was con-
ducted to explore the role of interactions between ciga-
rette smoking and phase I and phase II metabolic enzymes
in CRC, using a nested case-only study in a Chinese Han
population cohort.
Methods
Study population and sample collection
Participants in this study were selected from a CRC
cohort-study population as previously reported [17]. In
brief, from May 1989 to April 1990, a prospective cohort
study based on a CRC survey was initiated in Jiashan
County, Zhejiang province, China. The study population
was defined as all residents aged 30 yrs or older in 10
small towns. All subjects were ethnic Han Chinese and
residents in Jiashan County. Follow-up for the incidence
of cancer in the entire cohort was established by the can-
cer registry system and CRC reporting system in Jiashan
County. 207 individuals, who were diagnosed with CRC
before May 2005, comprised the subjects in this analysis.
841 unaffected subjects who were randomly selected from
the cohort population were analyzed to examine the
assumption of independence between genotypes and cig-
arette smoking. All subjects were interviewed through a
questionnaire, including demographic characteristics,
smoking habits, alcohol consumption, and disease his-
tory, by professionally trained interviewers. Subjects were
considered smokers if they had ever smoked at least one
cigarette per day for a period of a year more. The smoking
data obtained from study subjects included: the age the
subject started smoking, smoking frequency, smoking
duration, and inhalation for cigarette smokers. The ques-
tions on alcohol consumption included drinking status,
average frequency, types of drinks, and average consump-
tion. After informed consent was obtained from each par-
ticipant, 5 ml of blood was collected and stored at -60°C.
The project was approved by the Medical Ethical Commit-
tee of the College of Medicine, Zhejiang University.
Genotyping
Genomic DNA was extracted using the improved salting
out procedure. Di-allele -specific-amplification with artifi-
cially modified primer (di-ASA-AMP) was used to detect
the genotype of CYP1B1 C1294G [18]. Two pairs of prim-
ers (P1, P2, S1 and S2) are shown in Table 1. The primers
of S2 and P2 produced a band representing the C allele
(370 bp); the other pair of primer (S1 and P1) produced
a band representing the G allele (173 bp). The outer prim-
ers (P1 and P2) produced a common band (505 bp).
GSTM1 and GSTT1 genetic polymorphisms were detected
simultaneously in a single assay using a multiplex
polymerase chain reaction (PCR) approach [19]. The
beta-globin gene co-amplified as an internal positive con-
trol, whereas sterile H2O was substituted for genomic
DNA and served as a negative control. Positive and nega-BMC Cancer 2007, 7:115 http://www.biomedcentral.com/1471-2407/7/115
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tive control samples were analyzed in each experiment.
PCR primers are given in Table 1.
The polymerase chain reaction-restriction fragment length
polymorphism (PCR-RFLP) method was applied to detect
the  CYP1A2  C734A [20], CYP2E1  C-1019T [21], and
SULT1A1 G638A [22] genotypes. The primers and restric-
tion enzymes used for PCR-PFLP are shown in Table 1.
Reliability and validity of the polymorphism analysis
were assessed through a repeat analysis using a randomly
sampled 10% of the data. No discrepancies were found in
the present study.
Statistical analysis
The χ2-goodness-of-fit test was used to test the Hardy-
Weinberg equilibrium. For polymorphisms with a low
variant allele frequency, the homozygote for the variant
allele was combined with the heterozygote, including
gene CYP1B1 and SULT1A1. For certain genes, genotypes
were combined on the basis of a known phenotype-geno-
type relationship, for instance, the combination of
CYP1A2 734 CC and CA genotypes, CYP2E1 -1019 CT and
TT genotypes were defined as 'poor metabolizer', while
the AA genotype of CYP1A2  734 and CC genotype of
CYP2E1 -1019 were termed as 'extensive metabolizer'.
In order to estimate gene-gene and gene-environment
interactions, a case-only design was applied. The case-only
design is an efficient way of estimating gene-gene and
gene-environment interactions, but it cannot evaluate the
main effect of either [23-25]. Such interactions may be
obtained in a case-only design if independence between
genotypes and between genotypes and environment expo-
sure is assumed. Case-only odds ratios (COR) for the rel-
evant interactions and 95% confidence intervals (95%CI)
were estimated via unconditional logistic regression. Pos-
sible confounding variables included age, gender, ciga-
rette smoking, and alcohol consumption. Participants
with missing values for any of the variables in the regres-
sion model were omitted from the analysis.
All p-values are two-sided, and all analyses are carried out
using Stata Statistical Software version 8.0.
Results
Characteristics of patients with CRC
The characteristics of CRC patients are shown in Table 2.
50.7% of the participants were male and 49.3% female,
the mean age being 65.82 years (S.D. = 9.81 years). The
observed smoking rate (ever-smoking) was 40.6%, which
was lower than the rate of non-smoking (59.4%). Among
smokers, 31 presented a smoking history of more than 35
pack-years (36.9%), and 53 presented a smoking history
of more than 30 pack-years (63.1%). Excluding one miss-
ing response, the observed drinking rate was 28.5%, 35
patients (60.0%) declared moderate drinkers (drink less
than 50 g ethanol a day), and 24 patients (40%) declared
heavy drinkers.
The effect of gene-gene interaction on CRC
Table 3 presents the COR for interactions between geno-
types in CRC, as determined in the case-only design. All
genotype distributions conformed to Hardy-Weinberg
equilibrium in this population. A significant interaction
was observed between CYP1B1  1294G allele and
SULT1A1 638A allele, the COR being 2.67 (95%CI: 1.14–
Table 1: Primers and restriction enzymes used for genotyping analyses
Gene Primers(5'-3'; F = forward, R = reverse) Restriction enzyme
CYP1A2 C734A F: CCC AGA AGT GGA AAC TGA GA ApaI
R: GGG TTG AGA TGG AGA CAT TC
CYP1B1 C1294G P1: TGT CCT GGC CTT CCT TTA TGA -
P2: GCC TCT TGC TTC TTA TTG GCA -
S1: CCG GGT TAG GCC ACT TGA C -
S2: GTC TGT GAA TCA TGA CCG AC -
CYP2E1 C-1019T F: CCA GTC GAG TCT ACA TTG TCA RsaI
R: TTC ATT CTG TCT TCT AAC TGG
GSTM1 F: TTC TGG ATT GTA GCA GAT CA -
R: CGC CAT CTT GTG CTA CAT TGC -
GSTT1 F: GCC CTG GCT AGT TGC TGA AG -
R: GCA TCT GAT TTG GGG ACC ACA -
β-Globin F: CAA CTT CAT CCA CGT TCA CC -
R: GAA GAA CCA AGG ACA GGT AC -
SULT1A1 G638A F: GGT TGA GGA GTT GGC TCT GC HhaI
R: ATG AAC TCC TGG GGG ACG GTBMC Cancer 2007, 7:115 http://www.biomedcentral.com/1471-2407/7/115
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6.27). However, COR combinations for the other gene-
gene interactions were not significant at the five percent
level.
The effect of gene-environment interaction on CRC
COR for gene-environment interactions between meta-
bolic enzyme genotypes and cigarette smoking is shown
in Table 4. Case-only analyses revealed that an interaction
existed between cigarette smoking and CYP1B1  1294G
allele in CRC (COR = 2.62, 95%CI: 1.01–6.72), the COR
for the interaction between CYP1B1 1294G and smoking
history > 35 pack-years was 3.47 (95%CI: 1.12–10.80).
No other significant interactions between cigarette smok-
ing and other genotypes were observed.
Discussion
Epidemiological studies suggested that gene-gene and
gene-environment interactions were associated with can-
cer susceptibility, especially the relationship between met-
abolic enzyme genes and environmental carcinogens [26-
28]. Interactions between carcinogen-metabolizing
enzymes and environmental factors may have a marked
impact on the population attributable risk for cancer.
Therefore, the exploration of the role of gene-gene and
gene-environment interactions in low penetrance-genes
may elucidate the causation of common sporadic cancers.
In the present study, we examined gene-gene and gene-
environment interactions among 6 polymorphisms and
cigarette smoking through a case-only design.
Few studies have described the association between gene-
gene interactions and the risk of CRC to date. Sachse et al.
[8] conducted a multicenter case-only study on 490 CRC
patients and 593 controls, finding no significant interac-
tions between GST  and  CYP1A1. However, in a recent
case-control study in China, we have demonstrated that
the combinations of GSTT1  and  GSTM1  as well as
CYP1A1*2A and GSTT1 are significantly associated with
CRC [29]. Another study in Taiwan reported that the com-
bination of CYP2E1  and  GSTM1  was associated with
breast cancer without the habits of cigarette smoking and
alcohol consumption [30]. In contrast, we found no evi-
dence for a significant interaction between CYP2E1 and
GSTM1 as related to CRC in our study population.
It is of particular interest that we found a clear interaction
between CYP1B1 1294G allele and SULT1A1 638A allele
in this case-only study. This finding did not support the
hypotheses based on in vitro model studies [11,16], sug-
gesting that SULT1A1-213Arg (the 638G allele) and
CYP1B1 432Val (the 1294C allele) enzyme could protect
against chemical carcinogens. However, our current
knowledge about biotransformation of these carcinogens
by these two enzymes is based primarily on in vitro model
studies, which may not reflect the complicated situation
of carcinogen metabolism in vivo correctly. Bamber et al.
[31] reported that a significantly reduced risk of CRC (OR
= 0.47; 95% CI: 0.27–0.83) was associated with the
SULT1A1 638GG genotype in Caucasian subjects under
the age of 80. Similar findings have also been reported in
the study of other cancers. Dandara et al. [32] revealed
that the homozygous SULT1A1 638AA genotype was asso-
ciated with increased risk for oesophageal cancer among
smokers. And another study [33] on lung cancer in the
Chinese population (805 cases and 809 controls)
reported that the variant A allele of SULT1A1 was associ-
ated with an increased risk of lung cancer (OR, 1.85; 95%
CI, 1.44–2.37). Furthermore, these authors showed that
Table 2: Characteristics of CRC study patients
Gender
Male 105(50.7%)
Female 102(49.3%)
Age (years)
< 54 28(13.5%)
54–60 40(19.3%)
61–71 70(33.8%)
> 71 69(33.3%)
Cigarette smoking
Non-smoker 123(59.4%)
Smoker 84(40.6%)
History (pack-years)
≤ 35 51(24.6%)
> 35 31(15.0%)
No response 2 (1%)
Alcohol consumption
Non-drinker 147(71.0%)
Moderate drinker (< 50 g ethanol/day) 35(16.9%)
Heavy drinker (≥ 50 g ethanol/day) 24(11.6%)
No response 1 (0.5%)BMC Cancer 2007, 7:115 http://www.biomedcentral.com/1471-2407/7/115
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the increased risk of lung cancer related to the variant
SULT1A1  genotypes was more pronounced in younger
subjects and limited to smokers. A case-only study on 282
women with breast cancer found that smokers carrying
the SULT1A1 638 A allele had a two-fold increase in risk
compared to non-smokers carrying the SULT1A1 638GG
genotype (OR = 2.55, 95%CI: 1.21–5.36), and smokers
carrying the CYP1B1 1294G allele also had a higher risk of
breast cancer than non-smokers carrying the 1294CC gen-
otype (OR = 2.32, 95%CI: 1.00–5.38) [34]. These findings
indicated that SULT1A1 and CYP1B1, among many other
metabolic pathways, may not be of importance in the
metabolic activation of these carcinogens in vivo.
However, other possibilities may also exist for the expla-
nation of our results. Accumulating evidence suggested
that CRC is a hormone dependent tumor. For instance,
epidemiological studies found that a correlation existed
between breast cancer and colorectal cancer in women
[35,36]. A meta-analysis of seven cohort studies demon-
strated that a weak association existed between breast can-
cer and the subsequent risk of colorectal cancer (pooled
relative risk (RR) = 1.15; 95% CI = 0.99–1.31], and pooled
results from five cohort studies showed that the risk of
breast cancer after colorectal cancer was similar (pooled
RR = 1.10; 95% CI = 1.03–1.17) [37]. In addition, a meta-
analysis by Schoen et al. [38] indicated that women with
a history of breast, endometrial, or ovarian cancer are at a
statistically significant increased risk for subsequent color-
ectal cancer. The study of English et al. [39] indicated that
the loss of estrogen inactivation may be an important
mechanism in the pathogenesis of colonic cancer. The
normal colonic mucosa has a high level of 17beta-
hydroxysteroid dehydrogenase (17beta-HSD)-mediated
estradiol metabolism (inactivation of estradiol to
estrone), while the enzyme activity of 17beta-HSD was
significantly decreased in the tumor [40]. Taken together,
these findings suggest that the oestrogen metabolism in
vivo might be associated with increased risk of CRC.
CYP1B1 and SULT1A1 are all important estrogen-metab-
olizing enzymes. CYP1B1 is responsible for catalyzing the
formation of 4-hydroxy-estradiol, while SULT1A1 is
involved in the inactivation of these carcinogens. The var-
iant of CYP1B1  displayed increased catalytic efficiency
Table 3: Gene-gene interactions for combinations of metabolic enzymes genotypes in CRC
Genotype CYP1A2 C734A AA CC+CA COR(95%CI)* P-value
GSTM1
Present 37 47 1.00 (Ref.) 0.14
Null 42 78 1.56(0.86–2.82)
GSTT1
Present 61 92 1.00 (Ref.) 0.59
Null 18 33 1.21(0.62–2.36)
SULT1A1
*1/*1 68 109 1.00 (Ref.) 0.86
*1/*2,*/*2 11 16 0.93(0.40–2.15)
CYP1B1C1294G CC CG+GG COR(95%CI)* P-value
GSTM1
Present 50 34 1.00 (Ref.) 0.16
Null 78 40 0.65(0.35–1.19)
GSTT1
Present 92 69 1.00 (Ref.) 0.08
Null 36 15 0.52(0.25–1.08)
SULT1A1
*1/*1 117 59 1.00 (Ref.) 0.02
*1/*2,*/*2 13 15 2.67(1.14–6.27)
CYP2E1 C-1019T CC CT+TT COR(95%CI)* P-value
GSTM1
Present 33 51 1.00 (Ref.) 0.23
Null 58 62 0.70(0.39–1.26)
GSTT1
Present 66 87 1.00 (Ref.) 0.42
Null 25 26 0.76(0.40–1.47)
SULT1A1
*1/*1 83 94 1.00 (Ref.) 0.12
*1/*2,*/*2 8 19 2.05(0.82–5.11)
* Unconditional logistic regression adjusted for gender, age, cigarette smoking and alcohol consumption.BMC Cancer 2007, 7:115 http://www.biomedcentral.com/1471-2407/7/115
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compared to the wild-type enzyme, and may be associated
with significant changes in oestrogen metabolism. The
combination of the CYP1B1  1294G allele and the
SULT1A1 638A allele with modified ability to metabolize
estrogens could increase the level of estrogen (i.e., 4-
hydroxy-estradiol), which may finally result in a differen-
tial susceptibility to CRC.
Our gene and environment combined analyses suggested
that a significant interaction, which may increase the risk
for CRC, exists between the CYP1B1 1294G allele and cig-
arette smoking. This finding also did not support the
hypothesis based on in vitro model studies [11], and no
reports have described the association between this gene-
environment interaction and CRC risk to date. However,
the same gene-environment interaction was reported in
studies on other cancers, the results of which were similar
to ours. Liang et al. [18] found that CYP1B1 432Val poly-
morphism may modulate individual susceptibility to lung
cancer among smokers in the Chinese population (OR:
2.78, 95%CI: 1.46–5.29). A case-only study on breast can-
cer also reported that the combination of cigarette smok-
ing and CYP1B1 1294G allele was associated with a higher
risk of breast cancer [34]. Taken together, in contrast to
the hypothesis based on the in vitro model studies, these
findings suggest that the 1294CC genotype may protect
against chemical carcinogens related to certain human
cancers, such as PAHs. In addition, whether tobacco con-
tains numerous carcinogens and compound(s) that assur-
edly cause human CRC still remains to be seen. Further
studies are needed to address these possibilities.
A few case-control studies have been published with
regard to the combination of GSTT1/GSTM1 and cigarette
smoking in association with CRC. A study of 952 rectal
cancer cases and 1205 controls in the United States found
that a borderline significant interaction existed between
the  GSTM1  null allele and cigarette smoking [41].
Another cohort study on smoking with a nested case-only
design also found a borderline significant interaction
between GSTM1 null and cigarette smoking [42]. How-
ever, two studies indicated that no significant interactions
between  GSTT1/GSTM1  and cigarette smoking were
observed [43,44], the results of which were similar to
ours. Larger studies are needed to explore the interactions
between the susceptible genes and smoking and to iden-
tify the underlying mechanisms of CRC.
One of the limitations of the case-only design is that, in
order to obtain gene-gene and gene-environment interac-
tions, independence between genotypes and between gen-
otypes and environment exposure must be assumed. In
this study, we validated this independence assumption
through the analysis of a relatively large number of
healthy subjects (n = 841, 62.55 ± 10.85 years) randomly
selected from the same cohort population. Another limi-
tation of the current study is that selection bias might
occur from all patients being cancer survivors at the time
Table 4: Gene-environment interactions for combination of metabolic enzymes and cigarette smoking in CRC
Genotype Cigarette smoking
Non-smoker Smoker COR (95%CI)* Smoking history (pack-years)
≤ 35 COR (95%CI) * > 35 COR (95%CI)*
CYP1A2 C734A
AA 50 29 1.00(ref.) 17 1.00(ref.) 12 1.00(ref.)
CA+CC 72 53 1.04(0.44–2.50) 33 1.13(0.42~3.01) 18 0.95(0.31~2.93)
CYP1B1 C1294G
CC 82 47 1.00(ref.) 31 1.00(ref.) 16 1.00(ref.)
CG+GG 40 35 2.62(1.01–6.72)# 19 1.92(0.72~5.11) 15 3.47(1.12~10.80)#
CYP2E1 C-1019T
CC 60 31 1.00(ref.) 18 1.00(ref.) 12 1.00(ref.)
CT+TT 62 51 1.83(0.76–4.40) 32 2.42(0.91~6.46) 18 1.49(0.49~4.53)
GSTM1
Present 52 32 1.00(ref.) 19 1.00(ref.) 12 1.00(ref.)
Null 70 50 1.53(0.62–3.75) 31 1.45(0.55~3.83) 18 1.77(0.58~5.44)
GSTT1
Present 94 59 1.00(ref.) 36 1.00(ref.) 21 1.00(ref.)
Null 28 23 1.32(0.49–3.51) 14 1.41(0.49~4.10) 9 1.79(0.53~6.10)
SULT1A1
*1/*1 106 72 1.00(ref.) 45 1.00(ref.) 25 1.00(ref.)
*1/*2,*2/*2 17 11 0.53(0.16–1.69) 5 0.41(0.11~1.60) 6 0.65(0.16~2.66)
* Unconditional logistic regression adjusted for gender, age and alcohol consumption; # P < 0.05BMC Cancer 2007, 7:115 http://www.biomedcentral.com/1471-2407/7/115
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of analysis. However, since we used incident cases
recruited from the cohort population, our findings are
unlikely to be attributable to selection bias.
Conclusion
Our results showed that the interaction between polymor-
phisms in CYP1B1 1294G and SULT1A1*2 play a signifi-
cant role on CRC in Chinese people, and the association
between cigarette smoking and CRC can be differentiated
by the CYP1B1 1294G allele. However, these preliminary
exploratory results should be confirmed in larger studies.
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